The Role of Mass Spectrometry in the “Omics” Era

Author(s): Francesco Di Girolamo, Isabella Lante, Maurizio Muraca, Lorenza Putignani

Journal Name: Current Organic Chemistry

Volume 17 , Issue 23 , 2013

Become EABM
Become Reviewer
Call for Editor


Mass spectrometry (MS) is one of the key analytical technology on which the emerging ‘‘-omics’’ approaches are based. It may provide detection and quantization of thousands of proteins and biologically active metabolites from a tissue, body fluid or cell culture working in a ‘‘global’’ or ‘‘targeted’’ manner, down to ultra-trace levels. It can be expected that the high performance of MS technology, coupled to routine data handling, will soon bring fruit in the request for a better understanding of human diseases, leading to new molecular biomarkers, hence affecting drug targets and therapies.

In this review, we focus on the main advances in the MS technologies, influencing genomics, transcriptomics, proteomics, lipidomics and metabolomics fields, up to the most recent MS applications to meta-omic studies.

Keywords: Mass spectrometry, MS, MS-based genomics, MS-based proteomics, MS-based metabolomics, MS-based lipidomics, Meta-omics.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 18 December, 2013
Page: [2891 - 2905]
Pages: 15
DOI: 10.2174/1385272817888131118162725

Article Metrics

PDF: 78